Retractable Technologies (RVP) Share-based Compensation (2011 - 2024)
Retractable Technologies' (RVP) quarterly Share-based Compensation came in at $2.0 million in Q4 2024, up 1259.16% on a YoY basis from $147150.0 in Q1 2024, and up 1259.16% quarter-over-quarter from $147150.0 in Q4 2023.
Powered by 
Analysis
Retractable Technologies (RVP) Share-based Compensation (2011 - 2024) Analysis & Trends
Retractable Technologies (RVP) has reported Share-based Compensation for 12 consecutive years, with $2.0 million the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Share-based Compensation rose 1259.16% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2024 stood at $2.0 million (up 1259.16% YoY), and the FY2024 full-year result was $2.0 million, up 1259.16% from the prior year.
- Share-based Compensation climbed to $2.0 million in Q4 2024 per RVP's latest filing, from $147150.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.7 million in Q4 2022 and bottomed at $147150.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $1.8 million across 4 years, with a median of $1.2 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation slumped 97.8% in 2023, then soared 1259.16% in 2024.
- Over 4 years, Share-based Compensation stood at $1.2 million in 2021, then surged by 478.26% to $6.7 million in 2022, then plunged by 97.8% to $147150.0 in 2023, then jumped by 1259.16% to $2.0 million in 2024.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.0 million, $147150.0, and $6.7 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 55.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 274.00 Mn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 10.90 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 33.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -20,922.51 |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 2.96 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | - |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 147,150.00 |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 1.16 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Dec 31, 2019 | 639,300.00 |
| Dec 31, 2018 | 1.30 Mn |
| Dec 31, 2017 | 19,361.00 |
| Sep 30, 2017 | 182,551.00 |
| Jun 30, 2017 | 235,411.00 |
| Mar 31, 2017 | 234,898.00 |
| Dec 31, 2016 | 303,075.00 |
| Sep 30, 2016 | 83,901.00 |
| Mar 31, 2016 | 750.00 |
| Dec 31, 2015 | 2.13 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Dec 31, 2012 | 3.37 Mn |